Delving into the Latest Updates on Artichoke extract with Synapse

Overview

Basic Info

Drug Type

Herbal medicine

Synonyms-

Target-

Action-

Mechanism-

Therapeutic Areas

NeoplasmsRespiratory DiseasesOther Diseases

Active Indication-

Inactive Indication

AsbestosisMesothelioma

Originator Organization

Aboca S.p.A. Società Agricola

Active Organization-

Inactive Organization

Aboca S.p.A. Società Agricola

Drug Highest PhasePendingPhase 2

First Approval Date-

Regulation-

Login to view timeline

This is a single-arm phase II trial to assess the biological activity (in a sub-cohort using a Simon two-stage Phase II design) and toxicity of Artichoke Whole Phytocomplex Concentrate (WPC). The objective of the study is to explore the potential for a non-toxic phytocomplex extract from the artichoke plant as a chemoprevention agent.

Start Date05 Nov 2019

Sponsor / Collaborator

Ontario Clinical Oncology Group

[+1]

100 Clinical Results associated with Artichoke extract

Login to view more data

100 Translational Medicine associated with Artichoke extract

Login to view more data

100 Patents (Medical) associated with Artichoke extract

Login to view more data

100 Deals associated with Artichoke extract

Login to view more data